Latest Articles
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer OncLive
Published: Oct. 24, 2024, 3:55 p.m.
Pharmacokinetic Relationship Between GLP-1s, Endometrial Cancer Cell Growth - DocWire News
Pharmacokinetic Relationship Between GLP-1s, Endometrial Cancer Cell Growth DocWire News
Published: Oct. 24, 2024, 2:55 p.m.
Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer - Medscape
Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer Medscape
Published: Oct. 24, 2024, 1:44 p.m.
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace
Published: Oct. 24, 2024, 11:46 a.m.
Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com
Approval From European Commission With Two New Indications in Gynecologic Cancers businesswire.com
Published: Oct. 24, 2024, 10:45 a.m.
‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? - Medscape
‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? Medscape
Published: Oct. 24, 2024, 9:51 a.m.
Factors in malignant transformation of ovarian endometriosis: A narrative review.
Endometriosis is a common estrogen-dependent inflammatory disease with a chronic course and a tendency to recur. The association between endometriosis and cancer has been studied for several years. Numerous reports …
Published: Oct. 24, 2024, midnight
There's still a lot we don't know about ovarian cancer, says Colorado doctor - MSN
There's still a lot we don't know about ovarian cancer, says Colorado doctor MSN
Published: Oct. 23, 2024, 10:29 p.m.
Efficacy, Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer - Medpage Today
Efficacy, Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer Medpage Today
Published: Oct. 23, 2024, 2:47 p.m.
ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer - Medpage Today
ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer Medpage Today
Published: Oct. 23, 2024, 2:47 p.m.
Link copied to clipboard!